173 related articles for article (PubMed ID: 23386105)
1. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.
Fanciullino R; Mollard S; Giacometti S; Berda-Haddad Y; Chefrour M; Aubert C; Iliadis A; Ciccolini J
Pharm Res; 2013 May; 30(5):1281-90. PubMed ID: 23386105
[TBL] [Abstract][Full Text] [Related]
2. Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.
Al Sabbagh C; Tsapis N; Novell A; Calleja-Gonzalez P; Escoffre JM; Bouakaz A; Chacun H; Denis S; Vergnaud J; Gueutin C; Fattal E
Pharm Res; 2015 May; 32(5):1585-603. PubMed ID: 25416027
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters.
Fanciullino R; Mollard S; Correard F; Giacometti S; Serdjebi C; Iliadis A; Ciccolini J
Pharm Res; 2014 Oct; 31(10):2677-84. PubMed ID: 24752479
[TBL] [Abstract][Full Text] [Related]
4. Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.
Fanciullino R; Giacometti S; Aubert C; Fina F; Martin PM; Piccerelle P; Ciccolini J
Pharm Res; 2005 Dec; 22(12):2051-7. PubMed ID: 16222443
[TBL] [Abstract][Full Text] [Related]
5. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
[TBL] [Abstract][Full Text] [Related]
6. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study.
Ahmed F; Kumari S; Kondapi AK
Pharm Res; 2018 Jul; 35(9):178. PubMed ID: 30014319
[TBL] [Abstract][Full Text] [Related]
9. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
[TBL] [Abstract][Full Text] [Related]
10. In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil.
Rahman Z; Kohli K; Zhang SQ; Khar RK; Ali M; Charoo NA; Tauseef M; Shamsher AA; Mohammed NN; Repka MA
J Pharm Pharmacol; 2008 May; 60(5):615-23. PubMed ID: 18416938
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
Ganguly K; Kulkarni AR; Aminabhavi TM
Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
Sun W; Chen Y; Yuan W
Int J Nanomedicine; 2013; 8():1499-506. PubMed ID: 23626465
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
[TBL] [Abstract][Full Text] [Related]
16. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
Gupta Y; Jain A; Jain P; Jain SK
J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
[TBL] [Abstract][Full Text] [Related]
17. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
19. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR
Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009
[TBL] [Abstract][Full Text] [Related]
20. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
